Leena Prasad
About Leena Prasad
Leena Prasad is a Senior Director of Drug Product Development with extensive experience in pharmaceutical sciences and drug development. She has held various leadership roles in companies such as Arcus Biosciences, AbbVie, and BridgeBio, and has a strong background in formulation development and CMC processes.
Current Role at BridgeBio
Leena Prasad serves as the Senior Director of Drug Product Development at BridgeBio, a position she has held since 2023. In this role, she oversees the development of drug products, leveraging her extensive experience in the pharmaceutical industry. Her responsibilities include managing cross-functional teams and ensuring the successful advancement of drug development projects.
Previous Experience at BridgeBio
Prior to her current role, Leena Prasad worked at BridgeBio as the Director of Drug Product Development from 2021 to 2023 and as the Associate Director of Drug Product Development from 2020 to 2021. During her tenure, she contributed to various projects, focusing on drug formulation and development strategies.
Experience at Arcus Biosciences
Leena Prasad was employed at Arcus Biosciences as the Associate Director of Preclinical Drug Development from 2018 to 2020. In this capacity, she played a key role in the early stages of drug development, focusing on preclinical assessments and strategies to advance drug candidates.
Education and Expertise
Leena Prasad earned her Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from The University of Texas at Austin, studying from 2013 to 2016. She also holds a Bachelor's Degree in Mechanical Engineering from the University of Illinois Urbana-Champaign, which she completed from 2001 to 2005. Her educational background supports her expertise in drug development, particularly in formulation techniques and quality by design.
Professional Skills and Specializations
Leena Prasad possesses a strong skill set in drug product development, including proficiency in hot melt extrusion and spray drying techniques. She specializes in bioavailability enhancing formulation and processing techniques, modified release, and formulation development. Her expertise extends to small molecules, solid form screening, and amorphous solid dispersions, making her a valuable asset in the pharmaceutical industry.